Trial Profile
Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2013
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate (Primary)
- Indications Ocular inflammation; Postoperative pain
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 26 Nov 2013 New trial record
- 18 Oct 2013 Pooled analysis published in Advances in Therapy.